FDA Finalizes Guidance on Labeling for Accelerated Approval Drugs

Drug Industry Daily
A A
The FDA released final guidance for sponsors on the indications and usage labeling section of drugs on the agency’s accelerated approval pathway.

To View This Article:

Login

Subscribe To Drug Industry Daily